Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis
Clinical trial NCT03508375 · UNKNOWN
Trial details
- NCT number
- NCT03508375
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2021-05-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.